Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.

The global Knee Osteoarthritis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Knee Osteoarthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Osteoarthritis Treatment.

Report Scope

The Knee Osteoarthritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Knee Osteoarthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Knee Osteoarthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Knee Osteoarthritis Treatment Market Report

Report Metric	Details
Report Name	Knee Osteoarthritis Treatment Market
CAGR	5%
Segment by Type	Non-surgical Treatment Surgical Treatment
Segment by Application	Hospitals Ambulatory Surgical Centers Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Knee Osteoarthritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Knee Osteoarthritis Treatment Market report?

Ans: The main players in the Knee Osteoarthritis Treatment Market are Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly

What are the Application segmentation covered in the Knee Osteoarthritis Treatment Market report?

Ans: The Applications covered in the Knee Osteoarthritis Treatment Market report are Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others

What are the Type segmentation covered in the Knee Osteoarthritis Treatment Market report?

Ans: The Types covered in the Knee Osteoarthritis Treatment Market report are Non-surgical Treatment, Surgical Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Non-surgical Treatment

1.2.3 Surgical Treatment

1.3 Market by Application

1.3.1 Global Knee Osteoarthritis Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Specialty Clinics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Knee Osteoarthritis Treatment Market Perspective (2019-2030)

2.2 Knee Osteoarthritis Treatment Growth Trends by Region

2.2.1 Global Knee Osteoarthritis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Knee Osteoarthritis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Knee Osteoarthritis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Knee Osteoarthritis Treatment Market Dynamics

2.3.1 Knee Osteoarthritis Treatment Industry Trends

2.3.2 Knee Osteoarthritis Treatment Market Drivers

2.3.3 Knee Osteoarthritis Treatment Market Challenges

2.3.4 Knee Osteoarthritis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Knee Osteoarthritis Treatment Players by Revenue

3.1.1 Global Top Knee Osteoarthritis Treatment Players by Revenue (2019-2024)

3.1.2 Global Knee Osteoarthritis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Knee Osteoarthritis Treatment Revenue

3.4 Global Knee Osteoarthritis Treatment Market Concentration Ratio

3.4.1 Global Knee Osteoarthritis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Knee Osteoarthritis Treatment Revenue in 2023

3.5 Knee Osteoarthritis Treatment Key Players Head office and Area Served

3.6 Key Players Knee Osteoarthritis Treatment Product Solution and Service

3.7 Date of Enter into Knee Osteoarthritis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Knee Osteoarthritis Treatment Breakdown Data by Type

4.1 Global Knee Osteoarthritis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2025-2030)

5 Knee Osteoarthritis Treatment Breakdown Data by Application

5.1 Global Knee Osteoarthritis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Knee Osteoarthritis Treatment Market Size (2019-2030)

6.2 North America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Knee Osteoarthritis Treatment Market Size by Country (2019-2024)

6.4 North America Knee Osteoarthritis Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Knee Osteoarthritis Treatment Market Size (2019-2030)

7.2 Europe Knee Osteoarthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Knee Osteoarthritis Treatment Market Size by Country (2019-2024)

7.4 Europe Knee Osteoarthritis Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Knee Osteoarthritis Treatment Market Size (2019-2030)

8.2 Asia-Pacific Knee Osteoarthritis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Knee Osteoarthritis Treatment Market Size (2019-2030)

9.2 Latin America Knee Osteoarthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Knee Osteoarthritis Treatment Market Size by Country (2019-2024)

9.4 Latin America Knee Osteoarthritis Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Knee Osteoarthritis Treatment Market Size (2019-2030)

10.2 Middle East & Africa Knee Osteoarthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bioventus

11.1.1 Bioventus Company Detail

11.1.2 Bioventus Business Overview

11.1.3 Bioventus Knee Osteoarthritis Treatment Introduction

11.1.4 Bioventus Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.1.5 Bioventus Recent Development

11.2 AVM Biotechnology

11.2.1 AVM Biotechnology Company Detail

11.2.2 AVM Biotechnology Business Overview

11.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Introduction

11.2.4 AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.2.5 AVM Biotechnology Recent Development

11.3 Anika Therapeutics

11.3.1 Anika Therapeutics Company Detail

11.3.2 Anika Therapeutics Business Overview

11.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Introduction

11.3.4 Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.3.5 Anika Therapeutics Recent Development

11.4 Flexion Therapeutics

11.4.1 Flexion Therapeutics Company Detail

11.4.2 Flexion Therapeutics Business Overview

11.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Introduction

11.4.4 Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.4.5 Flexion Therapeutics Recent Development

11.5 OrthoTrophix

11.5.1 OrthoTrophix Company Detail

11.5.2 OrthoTrophix Business Overview

11.5.3 OrthoTrophix Knee Osteoarthritis Treatment Introduction

11.5.4 OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.5.5 OrthoTrophix Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Detail

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Knee Osteoarthritis Treatment Introduction

11.6.4 Sanofi Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.6.5 Sanofi Recent Development

11.7 Horizon Therapeutics

11.7.1 Horizon Therapeutics Company Detail

11.7.2 Horizon Therapeutics Business Overview

11.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Introduction

11.7.4 Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.7.5 Horizon Therapeutics Recent Development

11.8 Johnson and Johnson

11.8.1 Johnson and Johnson Company Detail

11.8.2 Johnson and Johnson Business Overview

11.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Introduction

11.8.4 Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.8.5 Johnson and Johnson Recent Development

11.9 GlaxoSmithKline

11.9.1 GlaxoSmithKline Company Detail

11.9.2 GlaxoSmithKline Business Overview

11.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Introduction

11.9.4 GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.9.5 GlaxoSmithKline Recent Development

11.10 Bayer

11.10.1 Bayer Company Detail

11.10.2 Bayer Business Overview

11.10.3 Bayer Knee Osteoarthritis Treatment Introduction

11.10.4 Bayer Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.10.5 Bayer Recent Development

11.11 Abbott

11.11.1 Abbott Company Detail

11.11.2 Abbott Business Overview

11.11.3 Abbott Knee Osteoarthritis Treatment Introduction

11.11.4 Abbott Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.11.5 Abbott Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Detail

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Knee Osteoarthritis Treatment Introduction

11.12.4 Pfizer Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.12.5 Pfizer Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Detail

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Knee Osteoarthritis Treatment Introduction

11.13.4 Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2019-2024)

11.13.5 Eli Lilly Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Knee Osteoarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Non-surgical Treatment

Table 3. Key Players of Surgical Treatment

Table 4. Global Knee Osteoarthritis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Knee Osteoarthritis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Knee Osteoarthritis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Knee Osteoarthritis Treatment Market Share by Region (2019-2024)

Table 8. Global Knee Osteoarthritis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Knee Osteoarthritis Treatment Market Share by Region (2025-2030)

Table 10. Knee Osteoarthritis Treatment Market Trends

Table 11. Knee Osteoarthritis Treatment Market Drivers

Table 12. Knee Osteoarthritis Treatment Market Challenges

Table 13. Knee Osteoarthritis Treatment Market Restraints

Table 14. Global Knee Osteoarthritis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Knee Osteoarthritis Treatment Market Share by Players (2019-2024)

Table 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2023)

Table 17. Ranking of Global Top Knee Osteoarthritis Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Knee Osteoarthritis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Knee Osteoarthritis Treatment Product Solution and Service

Table 21. Date of Enter into Knee Osteoarthritis Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Knee Osteoarthritis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Knee Osteoarthritis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Knee Osteoarthritis Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Knee Osteoarthritis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Knee Osteoarthritis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Knee Osteoarthritis Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Knee Osteoarthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Knee Osteoarthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Knee Osteoarthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Knee Osteoarthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Knee Osteoarthritis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Knee Osteoarthritis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Knee Osteoarthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Knee Osteoarthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Knee Osteoarthritis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Knee Osteoarthritis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Bioventus Company Detail

Table 47. Bioventus Business Overview

Table 48. Bioventus Knee Osteoarthritis Treatment Product

Table 49. Bioventus Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 50. Bioventus Recent Development

Table 51. AVM Biotechnology Company Detail

Table 52. AVM Biotechnology Business Overview

Table 53. AVM Biotechnology Knee Osteoarthritis Treatment Product

Table 54. AVM Biotechnology Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 55. AVM Biotechnology Recent Development

Table 56. Anika Therapeutics Company Detail

Table 57. Anika Therapeutics Business Overview

Table 58. Anika Therapeutics Knee Osteoarthritis Treatment Product

Table 59. Anika Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 60. Anika Therapeutics Recent Development

Table 61. Flexion Therapeutics Company Detail

Table 62. Flexion Therapeutics Business Overview

Table 63. Flexion Therapeutics Knee Osteoarthritis Treatment Product

Table 64. Flexion Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 65. Flexion Therapeutics Recent Development

Table 66. OrthoTrophix Company Detail

Table 67. OrthoTrophix Business Overview

Table 68. OrthoTrophix Knee Osteoarthritis Treatment Product

Table 69. OrthoTrophix Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 70. OrthoTrophix Recent Development

Table 71. Sanofi Company Detail

Table 72. Sanofi Business Overview

Table 73. Sanofi Knee Osteoarthritis Treatment Product

Table 74. Sanofi Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 75. Sanofi Recent Development

Table 76. Horizon Therapeutics Company Detail

Table 77. Horizon Therapeutics Business Overview

Table 78. Horizon Therapeutics Knee Osteoarthritis Treatment Product

Table 79. Horizon Therapeutics Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 80. Horizon Therapeutics Recent Development

Table 81. Johnson and Johnson Company Detail

Table 82. Johnson and Johnson Business Overview

Table 83. Johnson and Johnson Knee Osteoarthritis Treatment Product

Table 84. Johnson and Johnson Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 85. Johnson and Johnson Recent Development

Table 86. GlaxoSmithKline Company Detail

Table 87. GlaxoSmithKline Business Overview

Table 88. GlaxoSmithKline Knee Osteoarthritis Treatment Product

Table 89. GlaxoSmithKline Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 90. GlaxoSmithKline Recent Development

Table 91. Bayer Company Detail

Table 92. Bayer Business Overview

Table 93. Bayer Knee Osteoarthritis Treatment Product

Table 94. Bayer Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 95. Bayer Recent Development

Table 96. Abbott Company Detail

Table 97. Abbott Business Overview

Table 98. Abbott Knee Osteoarthritis Treatment Product

Table 99. Abbott Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 100. Abbott Recent Development

Table 101. Pfizer Company Detail

Table 102. Pfizer Business Overview

Table 103. Pfizer Knee Osteoarthritis Treatment Product

Table 104. Pfizer Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 105. Pfizer Recent Development

Table 106. Eli Lilly Company Detail

Table 107. Eli Lilly Business Overview

Table 108. Eli Lilly Knee Osteoarthritis Treatment Product

Table 109. Eli Lilly Revenue in Knee Osteoarthritis Treatment Business (2019-2024) & (US$ Million)

Table 110. Eli Lilly Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Knee Osteoarthritis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Knee Osteoarthritis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Non-surgical Treatment Features

Figure 4. Surgical Treatment Features

Figure 5. Global Knee Osteoarthritis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Knee Osteoarthritis Treatment Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Ambulatory Surgical Centers Case Studies

Figure 9. Specialty Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Knee Osteoarthritis Treatment Report Years Considered

Figure 12. Global Knee Osteoarthritis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Knee Osteoarthritis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Knee Osteoarthritis Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Knee Osteoarthritis Treatment Market Share by Players in 2023

Figure 16. Global Top Knee Osteoarthritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Knee Osteoarthritis Treatment Revenue in 2023

Figure 18. North America Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Knee Osteoarthritis Treatment Market Share by Country (2019-2030)

Figure 20. United States Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Knee Osteoarthritis Treatment Market Share by Country (2019-2030)

Figure 24. Germany Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Knee Osteoarthritis Treatment Market Share by Region (2019-2030)

Figure 32. China Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Knee Osteoarthritis Treatment Market Share by Country (2019-2030)

Figure 40. Mexico Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Knee Osteoarthritis Treatment Market Share by Country (2019-2030)

Figure 44. Turkey Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Knee Osteoarthritis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Bioventus Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 47. AVM Biotechnology Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 48. Anika Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 49. Flexion Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 50. OrthoTrophix Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 52. Horizon Therapeutics Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 53. Johnson and Johnson Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 55. Bayer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 56. Abbott Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 57. Pfizer Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 58. Eli Lilly Revenue Growth Rate in Knee Osteoarthritis Treatment Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33E11182

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Rheumatic Disorders Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-15X13281

Mon Oct 14 00:00:00 UTC 2024

Add to Cart

Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29B5986

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Rheumatology Arthritis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1J13864

Sat Oct 05 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions